Developer docs
API playgroundTry for free, no card

Search company profiles

CVPath Institute

Full company profile

uuid0006uqn

Namestring
CVPath Institute
Legal namestring
CVPath Institute Inc.
Websiteurl
cvpath.org
Company typeenum
Private
Founded yearint
2005
Descriptiontext

CVPath Institute is a 501(c)(3) non-profit cardiovascular pathology research organization founded in 2005 by Dr. Renu Virmani and headquartered in Gaithersburg, Maryland, along the I-270 Technology Corridor. The institute provides expert translational bench-to-bedside research services to medical technology companies globally, ranging from startups to Fortune 100 manufacturers. Its portfolio covers histology, CAP-accredited and CLIA-approved diagnostic pathology for autopsy and surgical specimens, GLP-compliant preclinical device trials, medical device evaluation across the full cardiovascular anatomy, advanced imaging (including a custom Nikon XT H 225ST Micro-CT, OCT, IVUS, and NIR spectroscopy), and a molecular biology laboratory. The institute is also an educational organization, running a competitive 1-4 year fellowship program, summer internships, and the 'Hands on Hearts' cadaveric workshop delivered at major cardiovascular conferences (CRT, TCT).

Short descriptiontext

CVPath Institute is a 501(c)(3) non-profit cardiovascular pathology research organization providing histology, CAP/CLIA diagnostic, GLP preclinical, and consultation services to medical device companies globally, anchored by a 7,000+ autopsy-heart biobank.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersGaithersburg, United States
HQ citystring
Gaithersburg
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cardiovascular pathology research, preclinical medical device testing, cardiovascular tissue biobank, GLP-compliant histology services, diagnostic cardiovascular laboratory
Industry4 codes
PRIMARYHLAGACAG
Clinical Trial Monitoring Support (On-site/Remote)
SECONDARYHLAKABAA
General Cardiology (Consultative)
SECONDARYEDAGANAJ
Healthcare & Clinical Professional Development (CME/CE)
Education/Educational Publishing & Learning Content/Professional Development & Training Materials
SECONDARYEDAOAJAO
Clinical Research Support (CRC/CTA)
Education/Vocational, Technical & Trade Education/Healthcare Allied & Clinical Support Training
NAICS code3 codes
  • Research and Development in the Physical, Engineering, and Life Sciences54171
  • Medical and Diagnostic Laboratories6215
  • Other Scientific and Technical Consulting Services54169
SIC code4 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Medical Laboratories8071
  • Services-Educational Services8200
  • Services-Offices & Clinics Of Doctors Of Medicine8011
Product category
Cardiovascular Pathology Research Services
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model6 records
1Consultation Services
TypeProfessional Services
Description

Expert translational bench-to-bedside research services including guidance on device safety, mechanism of action studies, and FDA responses. Provided globally to companies from startups to Fortune 100 manufacturers.

cvpath.org
2Histology Services
TypeProfessional Services
Description

Comprehensive histology services including grossing, tissue processing (dehydration, clearing, infiltration), paraffin and plastic embedding and sectioning, H&E staining, frozen sectioning, and special stains for amyloids, bacteria, chemicals, and minerals.

cvpath.org
3Diagnostic Laboratory Services
TypeProfessional Services
Description

CAP-accredited and CLIA-approved diagnostic services for autopsy and surgical human specimens. Analysis includes heart tissue evaluation, endomyocardial biopsies, pericardial biopsy/resection, vascular specimens, cardiac device examination, and congenital heart disease devices.

cvpath.org
4Preclinical Trials and Device Testing
TypeProfessional Services
Description

Study design consultation and small-scale device testing in vascular restenosis models from feasibility through GLP compliant regulatory submission. In-house preclinical models include small animals (rabbits and swine) with acute and chronic study capabilities. Services include biocompatibility, safety, and pharmacokinetic testing.

cvpath.org
5Imaging Services
TypeProfessional Services
Description

Ex-vivo and in-vivo intravascular imaging tools including OCT, IVUS, angioscopy, near-infrared spectroscopy, and Micro-CT analysis. Coregistration services between histology and imaging modalities. State-of-the-art OCT core laboratory analysis.

cvpath.org
6Governmental, Philanthropic, and Private Sector Research Grants
TypeManaged Services
Description

The institute is supported by governmental, philanthropic, and private sector funding to conduct independent cardiovascular research. Examples include $10M GCRFF network grant for SHE-HEALS study and ARPA-H grant for smart stent research with Triton Systems.

cvpath.org
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

CVPath Institute is a non-profit 501(c)(3) research organization that provides expert translational bench-to-bedside cardiovascular pathology services to medical device companies and academic researchers. Its offerings span histology, CAP-accredited/CLIA-approved diagnostic pathology, GLP-compliant preclinical device testing, advanced imaging (OCT, Micro-CT, IVUS, NIR spectroscopy), molecular biology, and a 7,000+ heart tissue biobank, complemented by fellowship and educational programs.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • Over 7,000 autopsy hearts archived and analyzed for cardiovascular pathology research
+5 more records
Product overview1 text field

CVPath Institute is a non-profit medical research and educational organization (501(c)(3)) dedicated to cardiovascular pathology research and services. The organization offers a comprehensive suite of consultation and laboratory services rather than a unified software product. Core services include histology, diagnostic (CAP-accredited/CLIA-approved), preclinical trials, medical device evaluation, clinical specimen services, and advanced imaging (OCT, Micro-CT). Supporting capabilities include a Heart Lab, Molecular Biology Laboratory, Tissue Biobank (7,000+ autopsy hearts), Genomic Research Services, and Registry Studies. Educational offerings comprise the Hands on Hearts Workshop, Fellowship Program (1-4 years), and Summer Internship Program. Services are provided globally to medical device companies from startups to Fortune 100, supporting device safety evaluation, FDA responses, and regulatory submissions.

Product and service8 records
1Consultation Services
CategoryConsulting Services
Description

Expert translational bench-to-bedside research services for medical device companies, including guidance on device safety, mechanism of action studies, FDA responses, and regulatory consultation for 510K and IDE approvals.

2Histology Services
CategoryLaboratory Services
Description

Comprehensive histology services including grossing, tissue processing, paraffin and plastic embedding and sectioning, H&E staining, frozen sectioning, and special stains for identifying amyloids, bacteria, chemicals, and minerals in diseased tissue.

3Diagnostic Services
CategoryDiagnostic Laboratory Services
Description

CAP-accredited and CLIA-approved diagnostic services for autopsy and surgical human specimens including heart tissue evaluation, endomyocardial biopsies, vascular specimens, cardiac devices (stents, valves, pacemakers), and congenital heart disease devices.

4Preclinical Trials
CategoryPreclinical Research Services
Description

Study design consultation and small-scale device testing in vascular restenosis models from feasibility through GLP-compliant regulatory submission, including biocompatibility, safety, and pharmacokinetic testing using rabbit and swine coronary and peripheral models.

5Medical Device Evaluation
CategoryMedical Device Evaluation Services
Description

Expert pathology evaluation of medical devices across the entire anatomical cardiovascular territory including cerebral, carotid, aorta, heart valves, coronary arteries, renal, and peripheral devices with expertise in stent-grafts, TAVI, prosthetic valves, and drug-coated balloons.

6Clinical Specimen Services
CategoryDiagnostic Services
Description

Full array of diagnostic services for autopsy and surgical specimens including cardiovascular toxicity assessment, medical device evaluation, whole heart grossing, excised atherosclerotic plaque analysis, and thrombectomy material examination.

7Imaging Services
CategoryImaging Services
Description

Comprehensive microscopy technologies including Optical Coherence Tomography (OCT), Micro-CT imaging using a Nikon XT H 225ST scanner for nondestructive 3D imaging, intravascular ultrasound, angioscopy, and near-infrared spectroscopy with coregistration services between histology and imaging modalities.

8Tissue Biobank
Scale indicator12 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

CVPath is a participant in the SHE-HEALS study (Sex-specific Health Effects of Estrogen, Lipids, and Menopause: The Early After Menopause study), a $10 million network grant awarded by GCRFF through the International Research Challenge on Women's Cardiovascular Health. The consortium spans 13 institutions across 7 countries and is led by BHF Professor Ziad Mallat (University of Cambridge) and Professor Martha Hickey (University of Melbourne). CVPath contributes cardiovascular pathology expertise to investigate how menopause shapes heart health.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Together with Triton Systems, CVPath was awarded a grant from the Advanced Research Projects Agency for Health (ARPA-H) to study 'Continuous Monitoring of Cardiovascular Health Using Smart Stents' (ARPA-H-03). The project evaluates the use of a novel 'smart stent' capable of providing real-time information about hemodynamics and troponin-sensing.

3Office of the Chief Medical Examiner of the State of Maryland
Strategic tierCoreTypeOthers
Description

CVPath has collected over 7,000 autopsy hearts from the Office of the Chief Medical Examiner of the State of Maryland and other contributors since the 1990s. This partnership forms the foundation of the institute's biorepository and sudden death registry.

cvpath.org
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1NAMSA
TypeDirect peer
Description

NAMSA is the largest specialty medical device CRO, offering GLP preclinical testing, biocompatibility, regulatory consulting, and pathology support. It is the most direct comparable to CVPath's preclinical, GLP, and regulatory submission services for medical device manufacturers.

TypeDirect peer
Description

Baim Institute (formerly Harvard Clinical Research Institute) is a cardiovascular-focused clinical research organization offering clinical trial design, regulatory support, and outcomes research to medical device and pharmaceutical sponsors. Comparable to CVPath as a cardiovascular-specialized research partner for device manufacturers.

TypeDirect peer
Description

CRF runs the TCT conferences and runs clinical research and education programs in interventional cardiology. Like CVPath, it serves as a translational hub connecting cardiovascular device manufacturers, physicians, and researchers, with overlapping scientific leadership communities.

TypeBroad incumbent
Description

DCRI is one of the largest academic clinical research organizations globally, with deep cardiovascular clinical trial expertise for pharmaceutical and device sponsors. Comparable to CVPath as a cardiovascular CRO with research authority, though broader in scope and anchored to Duke rather than pathology-focused.

TypeBroad incumbent
Description

Charles River is a global CRO with extensive preclinical, GLP, and safety testing services across medical device and pharma. It competes with CVPath for medical device preclinical work but operates at vastly greater scale and across many therapeutic areas.

6Eurofins Medical Device Testing
TypeBroad incumbent
Description

Eurofins runs a global network of medical device testing labs including biocompatibility, GLP preclinical, and material characterization. Comparable to CVPath as a service provider for medical device safety and regulatory submissions, though far broader and less specialty-cardiovascular focused.

TypeBroad incumbent
Description

Medpace is a mid-sized CRO with significant cardiovascular clinical trial experience. Comparable to CVPath as a CRO partner for cardiovascular sponsors, though at clinical-stage scale rather than preclinical/GLP pathology.

TypeBroad incumbent
Description

ICON is a top-5 global CRO offering preclinical, clinical, and regulatory services with cardiovascular subspecialty expertise. Comparable in being a one-stop partner for medical device regulatory pathways, though CVPath's cardiology pathology depth is uniquely specialized.

TypeBroad incumbent
Description

ARUP is a large academic reference laboratory offering specialty pathology and clinical diagnostics. Comparable to CVPath's CAP/CLIA-accredited diagnostic laboratory practice, though ARUP covers broad anatomic and clinical pathology rather than cardiovascular-focused.

TypeEmerging player
Description

Pacific BioLabs was a specialty medical device preclinical testing CRO before its Eurofins acquisition, offering GLP services similar to CVPath's preclinical offerings to Bay Area device manufacturers. Comparable as a smaller, specialty device-testing CRO with overlapping service lines.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CVPath Institute

Cardiovascular Pathology Research Servicescvpath.org

CVPath Institute is a 501(c)(3) non-profit cardiovascular pathology research organization providing histology, CAP/CLIA diagnostic, GLP preclinical, and consultation services to medical device companies globally, anchored by a 7,000+ autopsy-heart biobank.

What CVPath Institute does

CVPath Institute is a 501(c)(3) non-profit cardiovascular pathology research organization founded in 2005 by Dr. Renu Virmani and headquartered in Gaithersburg, Maryland, along the I-270 Technology Corridor. The institute provides expert translational bench-to-bedside research services to medical technology companies globally, ranging from startups to Fortune 100 manufacturers. Its portfolio covers histology, CAP-accredited and CLIA-approved diagnostic pathology for autopsy and surgical specimens, GLP-compliant preclinical device trials, medical device evaluation across the full cardiovascular anatomy, advanced imaging (including a custom Nikon XT H 225ST Micro-CT, OCT, IVUS, and NIR spectroscopy), and a molecular biology laboratory. The institute is also an educational organization, running a competitive 1-4 year fellowship program, summer internships, and the 'Hands on Hearts' cadaveric workshop delivered at major cardiovascular conferences (CRT, TCT).

CVPath Institute firmographics

Firmographics
Name
CVPath Institute
Legal name
CVPath Institute Inc.
Website
https://cvpath.org
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
11–50 employees
Short description
CVPath Institute is a 501(c)(3) non-profit cardiovascular pathology research organization providing histology, CAP/CLIA diagnostic, GLP preclinical, and consultation services to medical device companies globally, anchored by a 7,000+ autopsy-heart biobank.
Ownership category
akta.pro rank

CVPath Institute industry classification

Industry
Product category
Cardiovascular Pathology Research Services
NAICS
Research and Development in the Physical, Engineering, and Life Sciences (54171), Medical and Diagnostic Laboratories (6215), Other Scientific and Technical Consulting Services (54169)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071), Services-Educational Services (8200), Services-Offices & Clinics Of Doctors Of Medicine (8011)
akta.pro industry
PRIMARYHLAGACAG
Clinical Trial Monitoring Support (On-site/Remote)
SECONDARYHLAKABAA
General Cardiology (Consultative)
SECONDARYEDAGANAJ
Healthcare & Clinical Professional Development (CME/CE)
Education/Educational Publishing & Learning Content/Professional Development & Training Materials
SECONDARYEDAOAJAO
Clinical Research Support (CRC/CTA)
Education/Vocational, Technical & Trade Education/Healthcare Allied & Clinical Support Training

Keywords

  • Cardiovascular pathology research
  • Preclinical medical device testing
  • Cardiovascular tissue biobank
  • GLP-compliant histology services
  • Diagnostic cardiovascular laboratory

Where CVPath Institute is headquartered

Location

Headquarters

HQ city
Gaithersburg
HQ country
United States
HQ region
North America

Offices1 record

Markets served

CVPath Institute business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

  1. Consultation Services: Expert translational bench-to-bedside research services including guidance on device safety, mechanism of action studies, and FDA responses. Provided globally to companies from startups to Fortune 100 manufacturers.
  2. Histology Services: Comprehensive histology services including grossing, tissue processing (dehydration, clearing, infiltration), paraffin and plastic embedding and sectioning, H&E staining, frozen sectioning, and special stains for amyloids, bacteria, chemicals, and minerals.
  3. Diagnostic Laboratory Services: CAP-accredited and CLIA-approved diagnostic services for autopsy and surgical human specimens. Analysis includes heart tissue evaluation, endomyocardial biopsies, pericardial biopsy/resection, vascular specimens, cardiac device examination, and congenital heart disease devices.
  4. Preclinical Trials and Device Testing: Study design consultation and small-scale device testing in vascular restenosis models from feasibility through GLP compliant regulatory submission. In-house preclinical models include small animals (rabbits and swine) with acute and chronic study capabilities. Services include biocompatibility, safety, and pharmacokinetic testing.
  5. Imaging Services: Ex-vivo and in-vivo intravascular imaging tools including OCT, IVUS, angioscopy, near-infrared spectroscopy, and Micro-CT analysis. Coregistration services between histology and imaging modalities. State-of-the-art OCT core laboratory analysis.
  6. Governmental, Philanthropic, and Private Sector Research Grants: The institute is supported by governmental, philanthropic, and private sector funding to conduct independent cardiovascular research. Examples include $10M GCRFF network grant for SHE-HEALS study and ARPA-H grant for smart stent research with Triton Systems.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

CVPath Institute product offering

Product offering

Core offering

CVPath Institute is a non-profit 501(c)(3) research organization that provides expert translational bench-to-bedside cardiovascular pathology services to medical device companies and academic researchers. Its offerings span histology, CAP-accredited/CLIA-approved diagnostic pathology, GLP-compliant preclinical device testing, advanced imaging (OCT, Micro-CT, IVUS, NIR spectroscopy), molecular biology, and a 7,000+ heart tissue biobank, complemented by fellowship and educational programs.

Product overview

CVPath Institute is a non-profit medical research and educational organization (501(c)(3)) dedicated to cardiovascular pathology research and services. The organization offers a comprehensive suite of consultation and laboratory services rather than a unified software product. Core services include histology, diagnostic (CAP-accredited/CLIA-approved), preclinical trials, medical device evaluation, clinical specimen services, and advanced imaging (OCT, Micro-CT). Supporting capabilities include a Heart Lab, Molecular Biology Laboratory, Tissue Biobank (7,000+ autopsy hearts), Genomic Research Services, and Registry Studies. Educational offerings comprise the Hands on Hearts Workshop, Fellowship Program (1-4 years), and Summer Internship Program. Services are provided globally to medical device companies from startups to Fortune 100, supporting device safety evaluation, FDA responses, and regulatory submissions.

Differentiator

Problem solved

Functional benefit

Products and services

  • Consultation Services Expert translational bench-to-bedside research services for medical device companies, including guidance on device safety, mechanism of action studies, FDA responses, and regulatory consultation for 510K and IDE approvals.
  • Histology Services Comprehensive histology services including grossing, tissue processing, paraffin and plastic embedding and sectioning, H&E staining, frozen sectioning, and special stains for identifying amyloids, bacteria, chemicals, and minerals in diseased tissue.
  • Diagnostic Services CAP-accredited and CLIA-approved diagnostic services for autopsy and surgical human specimens including heart tissue evaluation, endomyocardial biopsies, vascular specimens, cardiac devices (stents, valves, pacemakers), and congenital heart disease devices.
  • Preclinical Trials Study design consultation and small-scale device testing in vascular restenosis models from feasibility through GLP-compliant regulatory submission, including biocompatibility, safety, and pharmacokinetic testing using rabbit and swine coronary and peripheral models.
  • Medical Device Evaluation Expert pathology evaluation of medical devices across the entire anatomical cardiovascular territory including cerebral, carotid, aorta, heart valves, coronary arteries, renal, and peripheral devices with expertise in stent-grafts, TAVI, prosthetic valves, and drug-coated balloons.
  • Clinical Specimen Services Full array of diagnostic services for autopsy and surgical specimens including cardiovascular toxicity assessment, medical device evaluation, whole heart grossing, excised atherosclerotic plaque analysis, and thrombectomy material examination.
  • Imaging Services Comprehensive microscopy technologies including Optical Coherence Tomography (OCT), Micro-CT imaging using a Nikon XT H 225ST scanner for nondestructive 3D imaging, intravascular ultrasound, angioscopy, and near-infrared spectroscopy with coregistration services between histology and imaging modalities.
  • Tissue Biobank

Quantifiable outcome

  • Over 7,000 autopsy hearts archived and analyzed for cardiovascular pathology research
  • +5 more outcomes

Companies that use CVPath Institute

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles3 records

CVPath Institute technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

CVPath Institute partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • Global Cardiovascular Research Funders' Forum (GCRFF) / SHE-HEALS ConsortiumcoreStrategic or Co-development PartnerCVPath is a participant in the SHE-HEALS study (Sex-specific Health Effects of Estrogen, Lipids, and Menopause: The Early After Menopause study), a $10 million network grant awarded by GCRFF through the International Research Challenge on Women's Cardiovascular Health. The consortium spans 13 institutions across 7 countries and is led by BHF Professor Ziad Mallat (University of Cambridge) and Professor Martha Hickey (University of Melbourne). CVPath contributes cardiovascular pathology expertise to investigate how menopause shapes heart health.
  • Triton SystemscoreStrategic or Co-development PartnerTogether with Triton Systems, CVPath was awarded a grant from the Advanced Research Projects Agency for Health (ARPA-H) to study 'Continuous Monitoring of Cardiovascular Health Using Smart Stents' (ARPA-H-03). The project evaluates the use of a novel 'smart stent' capable of providing real-time information about hemodynamics and troponin-sensing.
  • Office of the Chief Medical Examiner of the State of MarylandcoreOthersCVPath has collected over 7,000 autopsy hearts from the Office of the Chief Medical Examiner of the State of Maryland and other contributors since the 1990s. This partnership forms the foundation of the institute's biorepository and sudden death registry.

Scale indicators12 records

Recent moves6 records

Expansion highlights5 records

CVPath Institute competitors and assessment

Company assessment

Direct peers

  • NAMSA: NAMSA is the largest specialty medical device CRO, offering GLP preclinical testing, biocompatibility, regulatory consulting, and pathology support. It is the most direct comparable to CVPath's preclinical, GLP, and regulatory submission services for medical device manufacturers.
  • Baim Institute for Clinical Research: Baim Institute (formerly Harvard Clinical Research Institute) is a cardiovascular-focused clinical research organization offering clinical trial design, regulatory support, and outcomes research to medical device and pharmaceutical sponsors. Comparable to CVPath as a cardiovascular-specialized research partner for device manufacturers.
  • Cardiovascular Research Foundation (CRF): CRF runs the TCT conferences and runs clinical research and education programs in interventional cardiology. Like CVPath, it serves as a translational hub connecting cardiovascular device manufacturers, physicians, and researchers, with overlapping scientific leadership communities.

Broad incumbents

  • Duke Clinical Research Institute (DCRI): DCRI is one of the largest academic clinical research organizations globally, with deep cardiovascular clinical trial expertise for pharmaceutical and device sponsors. Comparable to CVPath as a cardiovascular CRO with research authority, though broader in scope and anchored to Duke rather than pathology-focused.
  • Charles River Laboratories: Charles River is a global CRO with extensive preclinical, GLP, and safety testing services across medical device and pharma. It competes with CVPath for medical device preclinical work but operates at vastly greater scale and across many therapeutic areas.
  • Eurofins Medical Device Testing: Eurofins runs a global network of medical device testing labs including biocompatibility, GLP preclinical, and material characterization. Comparable to CVPath as a service provider for medical device safety and regulatory submissions, though far broader and less specialty-cardiovascular focused.
  • Medpace: Medpace is a mid-sized CRO with significant cardiovascular clinical trial experience. Comparable to CVPath as a CRO partner for cardiovascular sponsors, though at clinical-stage scale rather than preclinical/GLP pathology.
  • ICON plc: ICON is a top-5 global CRO offering preclinical, clinical, and regulatory services with cardiovascular subspecialty expertise. Comparable in being a one-stop partner for medical device regulatory pathways, though CVPath's cardiology pathology depth is uniquely specialized.
  • ARUP Laboratories: ARUP is a large academic reference laboratory offering specialty pathology and clinical diagnostics. Comparable to CVPath's CAP/CLIA-accredited diagnostic laboratory practice, though ARUP covers broad anatomic and clinical pathology rather than cardiovascular-focused.

Emerging players

  • Pacific BioLabs (now part of Eurofins): Pacific BioLabs was a specialty medical device preclinical testing CRO before its Eurofins acquisition, offering GLP services similar to CVPath's preclinical offerings to Bay Area device manufacturers. Comparable as a smaller, specialty device-testing CRO with overlapping service lines.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

CVPath Institute social profiles

Digital presence

CVPath Institute compliance and trust

Trust signal

Compliance2 records

CVPath Institute financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CVPath Institute leadership team

Management profile

Number of profiles

Profiles9 records

CVPath Institute funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CVPath Institute M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CVPath Institute

What does CVPath Institute do?

CVPath Institute is a non-profit 501(c)(3) research organization that provides expert translational bench-to-bedside cardiovascular pathology services to medical device companies and academic researchers. Its offerings span histology, CAP-accredited/CLIA-approved diagnostic pathology, GLP-compliant preclinical device testing, advanced imaging (OCT, Micro-CT, IVUS, NIR spectroscopy), molecular biology, and a 7,000+ heart tissue biobank, complemented by fellowship and educational programs.

Is CVPath Institute a public or private company?

CVPath Institute is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was CVPath Institute founded?

CVPath Institute was founded in 2005. It employs 11 to 50 people.

Where is CVPath Institute based?

CVPath Institute is headquartered in Gaithersburg, United States, in the North America region.

How does CVPath Institute make money?

Six revenue lines are on record. Consultation Services are the primary driver. The others are histology Services, diagnostic Laboratory Services, preclinical Trials and Device Testing, imaging Services and governmental, Philanthropic, and Private Sector Research Grants.

Who are CVPath Institute's main competitors?

Direct peers on record are NAMSA, Baim Institute for Clinical Research and Cardiovascular Research Foundation (CRF). Broad incumbents are Duke Clinical Research Institute (DCRI), Charles River Laboratories, Eurofins Medical Device Testing, Medpace, ICON plc and ARUP Laboratories. Pacific BioLabs (now part of Eurofins) is listed as an emerging player.

Does CVPath Institute have an API?

No public API is recorded for CVPath Institute.

What industry is CVPath Institute in?

CVPath Institute's product category is Cardiovascular Pathology Research Services. Its primary akta.pro industry code is HLAGACAG, Clinical Trial Monitoring Support (On-site/Remote), with a secondary code of HLAKABAA, General Cardiology (Consultative). Its NAICS code is 54171 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals